// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Predicting challenge outcome in young people with persistent cow's milk allergy

Duca B - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

N/A

Preliminary results of a phase II trial of peanut oral immunotherapy in adults

Ue KL - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Coconut oral food challenge outcomes in a tertiary children's allergy service

Radulovic S - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implementation and evaluation of a novel antibiotic allergy diagnostic pathway in children

Grewal A - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The EAACI task force on chronic urticaria in children ‐ research and clinical network (CU‐kids)

Tsabouri S - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Dietary supplementation with a new immune tablet reduces antigen presentation and allergic symptoms in a poly‐sensitization BALB/c model

Afify SM - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Lactation anaphylaxis: A case presentation

Goss C - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

Methylprednisolone

Patient selection for venom immunotherapy improves after introduction of a clinical checklist

Mogg JAW - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Dietary supplementation with a new immune tablet ameliorates human symptom load during birch pollen season: lower B‐cell numbers yet with higher intracellular iron

Bartosik T - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Baseline characteristics from a phase 3, randomized controlled trial (COUGH‐1) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough

Muccino D - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Gefapixant

Analytical platform development for standardisation and quality control of major grass allergen content ‐ Lol p1 in grass allergoid vaccine

Starchenka S - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma

Slob EMA - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Compliance with UK tryptase requesting guidelines for assessment of anaphylaxis in a large NHS trust

Ajidagba N - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

N/A

EAACI task force logograms: Food allergy logogram to facilitate the diagnosis of food allergy in primary care

Flokstra - De Blok BMJ - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exploiting the EMR as a tool to facilitate asthma reviews

Ryan D - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Interweaving between genetic and epigenetic studies on asthma

Rathod A - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Progenitor cell‐derived basophil activation test (PCBAT) predicts clinical reactivity to cat better than skin prick test

Bennett M - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Daily peak expiratory flow (PEF) recordings obtained by a digital self‐monitoring device can predict asthma patients’ PEF zones of the next day

Sakkatos P - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Systemic corticosteroids in preschool wheeze and outcomes: The role of viruses

Ambrozej D - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Fully automated, precise measurement of EDN in nasal mucosal lining fluid

Pertsinidou E - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved